The Latest Breaking News from Grail

Garmin stock, along with Ollie's Bargain Outlet, are among the best stocks to watch on the stock market today.

The integrated cockpit and aero tubing are somewhat at odds with the Grail's taller stack height

With the rising investment in personalized medicine research and development and growing clinical trials, the biopharma industry’s prospects appear promising. Hence, quality biotech stocks, Alnylam Pharmaceuticals (ALNY), Illumina (ILMN), and Gilead Sciences (GILD) with long-term growth might be solid buys. Read more….

The biotech industry is well poised to flourish, buoyed by its strong emphasis on technology-driven advancements to address complex medical challenges and government funding. Hence, quality biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Compugen (CGEN) could be ideal watchlist additions for May. Read more….

Are we entering a new worldwide era for cancer screening?

Illumina stock rose Monday after the company said it would divest its cancer detection outfit, Grail, following a lengthy court battle.

Illumina said Sunday it will the sell cancer detection startup after a U.S. appeals court said the $7.1 billion deal violated antitrust laws,

Illumina, a beacon in genetic science, is set to unfurl its stake in Grail-the stellar creator of cancer-detecting tests–in a dance of corporate divestiture.

The healthcare industry is set for growth due to the growing demand for quality healthcare services and the integration of advanced technologies in offerings and operations. Therefore, it could be wise to buy fundamentally strong medical stocks HCA Healthcare (HCA), LifeVantage (LFVN), and Semler Scientific (SMLR). Read more….